ADALIMUMAB
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices
ADALIMUMAB (12420Q)
12420Q
Manner of administration:Injection
Restriction (Streamlined authority code: 17114)
Indication: Severe Crohn disease
Treatment phase: Subsequent continuing treatment of Crohn disease in a paediatric patient
